Post-meal blood sugar spikes may increase Alzheimer’s risk

A large genetic study has found that sharp rises in blood sugar after meals could significantly heighten the risk of Alzheimer’s disease. Researchers from the University of Liverpool analyzed data from over 350,000 UK Biobank participants, revealing a 69% increased risk linked to postprandial hyperglycemia. The effect appears independent of visible brain damage, pointing to subtler biological mechanisms.

Researchers at the University of Liverpool have uncovered evidence that post-meal blood sugar spikes may pose a greater threat to brain health than previously recognized. In a study published in Diabetes, Obesity and Metabolism in 2025, the team examined genetic and health data from more than 350,000 participants in the UK Biobank, all aged between 40 and 69. The analysis targeted metrics like fasting glucose, insulin levels, and blood sugar two hours after eating, employing Mendelian randomization to determine causal links to dementia.

The results highlighted a strong association between elevated post-meal glucose—termed postprandial hyperglycemia—and Alzheimer’s disease. Participants with higher levels faced a 69% greater risk, a connection not attributable to brain atrophy or white matter lesions. This suggests underlying pathways, possibly involving hidden metabolic effects, that warrant further investigation.

Conditions like type 2 diabetes and insulin resistance have long been tied to cognitive decline, but this research isolates after-meal spikes as a distinct factor. Lead author Dr. Andrew Mason noted, "This finding could help shape future prevention strategies, highlighting the importance of managing blood sugar not just overall, but specifically after meals."

Senior author Dr. Vicky Garfield emphasized the need for validation: "We first need to replicate these results in other populations and ancestries to confirm the link and better understand the underlying biology. If validated, the study could pave the way for new approaches to reduce dementia risk in people with diabetes."

These insights build on prior knowledge of hyperglycemia's role in dementia, potentially informing targeted interventions to safeguard brain health amid rising diabetes rates.

Related Articles

Conceptual illustration of gut bacteria producing inflammatory glycogen triggering brain inflammation in C9orf72-linked ALS and FTD, with stool sample comparisons and mouse treatment outcomes.
Image generated by AI

Study links microbial glycogen in the gut to inflammation in C9orf72-associated ALS and frontotemporal dementia

Reported by AI Image generated by AI Fact checked

Researchers at Case Western Reserve University report that some gut bacteria can make unusually inflammatory forms of glycogen and that this microbial glycogen can trigger immune activity linked to brain inflammation in models of disease tied to the C9orf72 mutation. In patient stool samples, the team found these glycogen forms more often in ALS and C9orf72-related frontotemporal dementia than in healthy controls, and enzymatically breaking down glycogen in the gut improved outcomes in mice.

New research from the University of Southern California suggests that subtle declines in brain blood flow and oxygen delivery may be early indicators of Alzheimer's disease. The study, published in Alzheimer's and Dementia, used noninvasive scans to connect vascular health with amyloid plaques and hippocampal shrinkage. These findings highlight the role of brain circulation in the disease process beyond traditional markers like amyloid and tau.

Reported by AI

Older adults carrying high-risk APOE4 gene variants experienced slower cognitive decline and lower dementia risk with higher meat consumption, according to a Karolinska Institutet study of over 2,100 participants tracked for up to 15 years. Findings suggest diet's effects on brain health vary by genetics, challenging one-size-fits-all advice.

A new study has found that adults with higher vitamin D levels in their 30s and 40s tend to have lower levels of tau protein in their brains about 16 years later. Tau is a key biomarker associated with dementia. The research, published this week, highlights a potential modifiable risk factor for brain health.

Reported by AI

A study involving 73 people with mild cognitive impairment or early dementia found that tailored treatment plans targeting nutritional deficiencies, infections and other factors led to significant cognitive improvements after nine months. Participants in the intervention group saw their overall cognitive scores rise by 13.7 points, while the control group declined by 4.5 points. The approach combines medical interventions with lifestyle changes like diet, exercise and cognitive training.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline